2005
DOI: 10.1016/j.ymthe.2005.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells

Abstract: Methylation of cytosines in CpG motifs is an important mechanism for epigenetic regulation of gene expression in mammalian cells. The initiating event(s) for de novo methylation in mammalian cells, particularly in cancer, is unknown. In plants, short RNAs homologous to DNA sequences are known to initiate de novo methylation. To investigate whether short hairpin RNAs (shRNAs) may also serve as initiators for de novo methylation in human cells we have expressed short hairpin RNAs complementary to the CpG island … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
107
0
1

Year Published

2007
2007
2013
2013

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 137 publications
(115 citation statements)
references
References 18 publications
7
107
0
1
Order By: Relevance
“…H3K9me3 was detected adjacent to the target region and we also found significant increase in its levels promoter-targeting siRNA-treated cells, which suggests that histone modification participates in gene silencing of HR-HPV E6 and E7 at the transcriptional level. Several publications also demonstrated the consistency between transcriptional gene silencing and DNA methylation in human cells (Morris et al, 2004;Castanotto et al, 2005). In our result, we found no methylation in the promoter of E6 and E7 with pyrosequencing.…”
Section: E6 E7supporting
confidence: 78%
“…H3K9me3 was detected adjacent to the target region and we also found significant increase in its levels promoter-targeting siRNA-treated cells, which suggests that histone modification participates in gene silencing of HR-HPV E6 and E7 at the transcriptional level. Several publications also demonstrated the consistency between transcriptional gene silencing and DNA methylation in human cells (Morris et al, 2004;Castanotto et al, 2005). In our result, we found no methylation in the promoter of E6 and E7 with pyrosequencing.…”
Section: E6 E7supporting
confidence: 78%
“…Since vertebrate genes are also characterized by extensive gene body methylation (Goll and Bestor, 2005;Klose and Bird, 2006), similar mechanisms could potentially apply for genes that are hypermethylated in cancer cells. In mammalian cells, a mechanistic link between siRNAs directed to promoters and induction of cytosine methylation has been convincingly demonstrated, which supports the basic existence of RdDMlike processes also in mammals (Morris et al, 2004;Castanotto et al, 2005). The existence of cancer cell or tumor-specific dsRNA is supported by a recent publication, which reports on natural antisense transcripts that are differentially expressed in various tumors (Klimov et al, 2006).…”
Section: Multiple Ways Of Recruiting Athda6?mentioning
confidence: 60%
“…However, similar mechanisms apparently exist in mammalian cells, suggesting the presence of functionally related components also in mammals. Short dsRNAs or siRNAs directed against promoters in mammalian cells cause transcriptional repression, but this is not always associated with DNA methylation (Morris et al, 2004;Castanotto et al, 2005;Ting et al, 2005;Weinberg et al, 2006). Although RNAi-mediated heterochromatin formation and RdDM have similar genetic requirements in Arabidopsis, suggesting a considerable overlap between these pathways, they can result in qualitatively distinct repressive chromatin at their targets (see below).…”
Section: Athda6: An Intimate Relationship With Transcriptional Rna Simentioning
confidence: 99%
“…TGS can be induced using siRNAs, antisense oligonucleotides [109], expressed antisense RNAs [110] or short hairpin RNAs [111,112]. And there are also examples of the successful implementation of this approach in vivo by local delivery in muscle [113], retina [112] and xenograft models [114].…”
Section: Gene-specific Epigenetic Therapymentioning
confidence: 99%